Atrium Therapeutics, Inc. (RNA) has a market capitalization of $217.52M and trades at $14.02. The 52-week range is 11.95-16.77.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.1, Earnings Per Share (EPS) of $-4.48, annual revenue of $18.62M.
The stock has a beta of 0.00, operates in the Healthcare sector.
